Literature DB >> 26110850

Correction: differential CARM1 isoform expression in subcellular compartments and among malignant and benign breast tumors.

David Shlensky, Jennifer A Mirrielees, Zibo Zhao, Lu Wang, Aparna Mahajan, Menggang Yu, Nathan M Sherer, Lee G Wilke, Wei Xu.   

Abstract

Entities:  

Year:  2015        PMID： 26110850      PMCID： PMC4482405          DOI： 10.1371/journal.pone.0131955

Source DB:  PubMed          Journal:  PLoS One        ISSN： 1932-6203            Impact factor:   3.240


× No keyword cloud information.
There are errors in panels A and C of Fig 2. The authors have provided a corrected version of Fig 2 here.
Fig 2

Immunofluorescence analysis of CARM1 localization in human cell lines.

(a, b) Localization of CARM1FL (E15) and total CARM1 (E16) in MDA-MB-231 cells. (c, d) Localization of CARM1FL (E15) and total CARM1 (E16) in BG-1 cells. (b) and (d) are quantification of immunofluorescence signals in cytoplasm and nucleus. DAPI: nuclear stain (blue). Phalloidin: cytoskeleton/actin probe (red). Student’s t test was used for statistical analysis. n = 3, *p < 0.05.

Immunofluorescence analysis of CARM1 localization in human cell lines.

(a, b) Localization of CARM1FL (E15) and total CARM1 (E16) in MDA-MB-231 cells. (c, d) Localization of CARM1FL (E15) and total CARM1 (E16) in BG-1 cells. (b) and (d) are quantification of immunofluorescence signals in cytoplasm and nucleus. DAPI: nuclear stain (blue). Phalloidin: cytoskeleton/actin probe (red). Student’s t test was used for statistical analysis. n = 3, *p < 0.05.
  1 in total

1.  Differential CARM1 Isoform Expression in Subcellular Compartments and among Malignant and Benign Breast Tumors.

Authors:  David Shlensky; Jennifer A Mirrielees; Zibo Zhao; Lu Wang; Aparna Mahajan; Menggang Yu; Nathan M Sherer; Lee G Wilke; Wei Xu
Journal:  PLoS One       Date:  2015-06-01       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.